A detailed history of Israel Englander (Millennium Management LLC) transactions in Next Cure, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 72,119 shares of NXTC stock, worth $93,754. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,119
Previous 458,340 84.27%
Holding current value
$93,754
Previous $728,000 86.54%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.33 - $1.78 $513,673 - $687,473
-386,221 Reduced 84.27%
72,119 $98,000
Q2 2024

Aug 14, 2024

SELL
$1.17 - $2.49 $790,613 - $1.68 Million
-675,738 Reduced 59.58%
458,340 $728,000
Q1 2024

May 15, 2024

SELL
$1.13 - $2.23 $7,131 - $14,073
-6,311 Reduced 0.55%
1,134,078 $2.53 Million
Q4 2023

Feb 14, 2024

SELL
$1.03 - $1.45 $276,725 - $389,565
-268,666 Reduced 19.07%
1,140,389 $1.3 Million
Q2 2023

Aug 14, 2023

SELL
$1.47 - $1.86 $66,098 - $83,634
-44,965 Reduced 3.09%
1,409,055 $2.54 Million
Q1 2023

May 15, 2023

BUY
$1.46 - $1.83 $170,855 - $214,153
117,024 Added 8.75%
1,454,020 $2.15 Million
Q4 2022

Feb 14, 2023

BUY
$1.2 - $3.07 $145,791 - $372,983
121,493 Added 10.0%
1,336,996 $1.89 Million
Q3 2022

Nov 14, 2022

BUY
$2.72 - $5.19 $275,027 - $524,776
101,113 Added 9.07%
1,215,503 $3.34 Million
Q2 2022

Aug 15, 2022

BUY
$3.38 - $5.27 $341,667 - $532,717
101,085 Added 9.98%
1,114,390 $5.24 Million
Q1 2022

May 16, 2022

BUY
$4.76 - $6.24 $25,308 - $33,178
5,317 Added 0.53%
1,013,305 $4.93 Million
Q4 2021

Feb 14, 2022

BUY
$5.7 - $9.1 $2.4 Million - $3.84 Million
421,860 Added 71.97%
1,007,988 $6.05 Million
Q3 2021

Nov 15, 2021

BUY
$6.74 - $8.02 $1.23 Million - $1.47 Million
182,814 Added 45.33%
586,128 $3.95 Million
Q2 2021

Aug 16, 2021

BUY
$7.6 - $10.28 $2.38 Million - $3.22 Million
313,220 Added 347.66%
403,314 $3.24 Million
Q1 2021

May 17, 2021

BUY
$9.81 - $13.88 $23,063 - $32,631
2,351 Added 2.68%
90,094 $902,000
Q4 2020

Feb 16, 2021

SELL
$9.47 - $12.43 $3.85 Million - $5.06 Million
-406,905 Reduced 82.26%
87,743 $956,000
Q3 2020

Nov 16, 2020

BUY
$8.15 - $21.17 $2.93 Million - $7.62 Million
359,964 Added 267.27%
494,648 $4.35 Million
Q2 2020

Aug 14, 2020

BUY
$21.19 - $40.2 $1.5 Million - $2.85 Million
70,967 Added 111.38%
134,684 $2.89 Million
Q1 2020

May 14, 2020

BUY
$32.32 - $58.37 $364,020 - $657,421
11,263 Added 21.47%
63,717 $2.36 Million
Q4 2019

Feb 14, 2020

BUY
$25.0 - $92.22 $1.31 Million - $4.84 Million
52,454 New
52,454 $2.96 Million
Q3 2019

Nov 14, 2019

SELL
$15.73 - $41.6 $474,055 - $1.25 Million
-30,137 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$14.16 - $20.64 $426,739 - $622,027
30,137 New
30,137 $451,000

Others Institutions Holding NXTC

About NextCure, Inc.


  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $36.1M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.